
Policy
Potential Inequities in New Medical Technologies
Even if we solve the ethical questions about using breakthrough techniques such as CRISPR, will all patients have equal access?
Jonathan Marron, MD, MPH, is a pediatric oncologist and researcher at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and a member of the teaching faculty at the Harvard Medical School Center for Bioethics.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account